Eve Health Group Limited announced that Mr. Rodney Hannington has joined the Company's board effective immediately as a Non-Executive Director. Mr. Hannington has been working in marketing and strategy services in consumer health and fast-moving consumer goods in the Asia Pacific region for over 15 years. He has valuable international experience in markets across Australia, China, Japan, South Korea and Southeast Asia.

Having worked with leading consulting firms, multinational companies such as Mondelez and Novartis and lived in Australia, China and Singapore, he has developed extensive experience with a strong network in the health and food industries. He is a strategic and innovative consumer health marketer with deep experience in Australia and China. He has led and been a part of several significant company acquisitions and new product launches in Australia and China as a board member, consultant and employee.

Mr. Hannington has been a member of the Monash University Department of Marketing Industry Advisory Board since 2013 and has held a variety of board roles at ASX listed companies, with a particular focus in the consumer health space. Mr. Hannington will bring a wealth of experience to the Company as it continues to develop the Meluka® brand in the probiotics space as well as investigating potential acquisitions of complementary businesses.